Scroll To Top
Search by Speciality

World Vaccine Congress Washington 2018

Renaissance Washington DC Downtown Hotel * | Washington, USA
From 2680 to 2975 USD
Event Preview
This event
is Finished
Title: World Vaccine Congress Washington 2018
Specialty: Internal Medicine
Dates: From Apr, 3, 2018 to Apr, 5, 2018
Location: Washington, USA
Type: Congress
Registration Cost: From 2680 to 2975 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for WASHINGTON, Usa.
General Info
Event Venue:

Renaissance Washington DC Downtown Hotel *

WASHINGTON, USA Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you. 

 By bringing eight events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just three days out of the office to meet over 700+ potential customers who need to find solutions to their challenges. 

Build three days of totally tailored content and attendees.  


Dr Gregory A. Poland , Director of Mayo Vaccine Research Group, Mayo Clinic 

Dr Justin Oritz , Affiliate Assistant Professor, Global Health, Affiliate Assistant Professor, Medicine Medical Officer, Initiative for Vaccine Research, World Health Organization 

Dr Carl R. Alving , Emeritus Senior Scientist, Former Chief, Laboratory of Adjuvant & Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research 

Dr Derek O'Hagan , Global Head of Discovery Support and New Technology, GSK Vaccines 

Prof Mathuram Santosham , Johns Hopkins University, Professor, Departments of International Health and Pediatrics, Director Emeritus, Center for American Indian Health 

Richard Hatchett , CEO, CEPI 

Dr Peter Hotez , Dean of National School of Tropical Medicine, Baylor College of Medicine 

Prof Stanley A. Plotkin , Emeritus Professor, University of Pennsylvania 

Rahul Singhvi , COO, Takeda 

Fred Moin Siyoi , Deputy Registrar, Pharmacy and Poisons Board, Nairobi, Kenya 

Dr Rip Ballou , Head US R&D Center, GSK Vaccines 

Dr Vasee Moorthy , Coordinator, Research, Ethics, Knowledge Uptake, Department of Information, Evidence and Research, & Team Leader, R&D Blueprint, WHO Geneva 

Dr Michael Kalos , Chief Scientific Officer, Cancer Immunobiology, Eli Lilly 

Dr Roy Baynes , Senior Vice President Global Clinical Development and Chief Medical Officer, MSD 

Dr Bruce Gellin , President of Global Immunization, Sabin Institute 

Jeff Stoddard , Medical Affair Lead for Zoster Vaccines, GSK Vaccines 

Prof Walter A. Orenstein , Professor and Associate Director; Influenza Pathogenesis & Immunology Research Center, Emory Vaccine Center 

Dr Paul Offit , Director of the Vaccine Education Centre, The Children’s Hospital of Philadelphia 

Dr Peter Kwong , Chief, Structural Biology Section, Vaccines Research Center, NIAID 

Prof Felix Rey , Head of Structural Biology, Institut Pasteur 

Dr Andrea Carfi , Senior Director, Antigen Design and Project Leader, Valera 

Dr Sumana Chandramouli , Laboratory Head, Preclinical R&D, GSK Vaccines 

Dr Hans Langedijk , Director Subunit Vaccine Design, Janssen Infectious Diseases and Vaccines 

Dr Vu L. Truong , Founder, Chief Executive Officer, and Director, Aridus 

Dr Steve Projan , Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious  Diseases and Vaccines, Medimmune

Dr Eszter Nagy , Co-Founder, Chief Scientific Officer, and Managing Director, Arsanis Biosciences GmbH 

Sushma Shivaswamy , Vice President, Research and Development, Xbiotech 

Todd Black , Executive Director Infectious Diseases, Head Antibacterial and Antifungal Discovery, Merck 

Surya Sankuratri , Executive Director, Business Development and Licensing, Merck 

Ana Maria Henao-Restrepo , MD, Team Leader, Implementation Research, Initiative for Vaccine Research, Department of Immunization, Vaccines & Biological, WHO 

Dr Ira Longini , Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida 

Bruno Speder , Head Clinical Regulatory Affairs & Consultancy, SGS Life Sciences 

Senior representative, PRA Health Sciences 

Geoffrey Glauser , Senior Consultant Supply Chain, HHS/ASPR/BARDA 

Senior representative, ClinicalRM 

Dr Lisa Plitnick , Senior Principal Scientist, Pre-Clinical Vaccine Safety, Merck & Co . 

More speakers TBC…

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2017-10-21 To: 0--
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


Renaissance Washington, DC Downtown Hotel

Seamlessly blending style, functionality, and comfort, the Renaissance Washington, DC Downtown Hotel welcomes you to the heart of the city with impeccable amenities and refined luxury. You're just moments from some of the most famous things to do and experience here in the Nation's Capital, including Chinatown, the White House, the National Portrait Gallery, and much more.

Limited rooms available at the venue. For alternative accommodation nearby please visit this link:

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Emerging science, technologies and collaborations are needed to make the necessary moves forward. As a provider of solutions to these issues, the event will provide a space for you to get in front of potential new customers from all walks of the vaccine industry.


Your Customers Will Be There To:

Hear insights from the world’s leading thinkers, practitioners and process disrupters

Evaluate and buy the latest technologies

Create new partnerships and gain investment

Have fun and do business

What A Great Opportunity To:

Debut new solutions

Improve your brand awareness

Meet new prospective clients

Maintain relationships

Pursue And Partner

Thousands of formal and informal meetings over just three days

30+ scientific posters

Three engaging networking lunches

Two networking drinks receptions

ViE Awards and Gala Dinner

Sponsors / Supporters

Gold Sponsor

PRA Health Sciences at World Vaccine Congress Washington 2018

Gold Sponsor

Valneva at World Vaccine Congress Washington 2018

Gold Sponsor

SGS at World Vaccine Congress Washington 2018

Gold Sponsor

INC Research at World Vaccine Congress Washington 2018

Gold Sponsor

ICON at World Vaccine Congress Washington 2018

Gold Sponsor

GE Healthcare at World Vaccine Congress Washington 2018

Silver Sponsor

Avanti Polar Lipids Inc at World Vaccine Congress Washington 2018

Silver Sponsor

Paragon Bioservices at World Vaccine Congress Washington 2018

Silver Sponsor

Viroclinics Biosciences at World Vaccine Congress Washington 2018

Silver Sponsor

Baxter BioPharma Solutions at World Vaccine Congress Washington 2018

Silver Sponsor

Nanotherapeutics at World Vaccine Congress Washington 2018

Silver Sponsor

MaxCyte at World Vaccine Congress Washington 2018

Exhibition Floor plans
Organising Agency

Terrapinn Holdings Ltd

Wren House

43 Hatton Garden



Tel: +44 (0)20 7092 1000

Fax: +44 (0)87 1233 9263

Event map
Revelant Events